FDA Warns Of High Mortality Rate with SynCardia Artificial Heart System
The FDA is warning that new drivers for the SynCardia System’s Temporary Total Artificial Heart (TAH-t) may increase the risk of death and strokes in patients.
The FDA is warning that new drivers for the SynCardia System’s Temporary Total Artificial Heart (TAH-t) may increase the risk of death and strokes in patients.
The FDA has released more data highlighting the mortality risks linked to a SynCardia heart transplant device linked to high death rates.
Two devices used to assist heart transplant patients have been linked to an increased risk of strokes, mortality and life-threatening malfunctions, according to a new warning by the FDA.